Rituximab treatment for adult patients with focal segmental glomerulosclerosis

Internal Medicine

Volumn 51, Issue 7, 2012, Pages 759-762

  Ochi, Ayami ^a   Takei, Takashi ^a   Nakayama, Kayu ^a   Iwasaki, Chihiro ^a   Kamei, Daigo ^a   Tsuruta, Yuki ^a   Shimizu, Ari ^a   Shiohira, Shunji ^a   Moriyama, Takahito ^a   Itabashi, Mitsuyo ^a   Mochizuki, Toshio ^a   Uchida, Keiko ^a   Tsuchiya, Ken ^a   Hattori, Motoshi ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Focal segmental glomerulosclerosis; Nephrotic syndrome; Rituximab

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTIC SYNDROME; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; REMISSION; SINGLE DRUG DOSE; STEROID DEPENDENT NEPHROTIC SYNDROME; STEROID RESISTANT NEPHROTIC SYNDROME;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; B-LYMPHOCYTES; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LYMPHOCYTE DEPLETION; MALE; NEPHROTIC SYNDROME; RECURRENCE; STEROIDS; YOUNG ADULT;

EID: 84859295374     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6854     Document Type: Article

References (15)

1. Meyrier AY. Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis? Kidney Int 76: 487-491, 2009.
2. Guigonis V, Dallocchio A, Baudouin V, et al. Rituximab treatment for severe steroid-or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23: 1269-1279, 2008.
3. Kamei K, Ito S, Nozu K, et al. Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 24: 1321-1328, 2009.
4. Hofstra JM, Deegens JK, Wetzels JF. Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome? Nephrol Dial Transplant 22: 2100-2102, 2007.
5. François H, Daugas E, Bensman A, Ronco P. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis 49: 158-161, 2007.
6. Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356: 2751-2752, 2007.
7. Maloney DG, Grillo-López AJ, White CA, et al. IDECC2B8 (RIT) anti-CD20 monoclonal antibody therapy in patients with relapsed low grade non-Hodgkin's lymphoma. Blood 90: 2188-2195, 1997.
8. Smith GC. Is there a role for rituximab in the treatment of idiopathic childhood nephritic syndrome? Pediatr Nephrol 22: 893-898, 2007.
9. Kurosu N, Sugiura H, Iwasaki C, et al. Successful use of singledose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome. Intern Med 48: 1901-1904, 2009.
10. Sawara Y, Itabashi M, Kojima C, et al. Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome. Clin Nephrol 72: 69-72, 2009.
11. Amemiya N, Takei T, Kojima C, Nokiba H, Itabashi M, Nitta K. Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome. Clin Exp Nephrol 15: 933-936, 2011.
12. Gulati A, Sinha A, Jordan SC, et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and-dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5: 2207-2212, 2010.
13. Grcevska L, Polenakovik M. Collapsing glomerulopathy: clinical characteristics and follow-up. Am J Kidney Dis 33: 652-657, 1999.
14. Singh HK, Baldree LA, McKenney DW, Hogan SL, Jennette JC. Idiopathic collapsing glomerulopathy in children. Pediatr Nephrol 14: 132-137, 2000.
15. Kaito H, Kamei K, Kikuchi E, et al. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Pediatr Nephrol 25: 957-959, 2010.